Sign in Subscribe
Class action lawsuits

Pomerantz LLP Announces Class Action Lawsuit Against Reckitt Benckiser Group Plc

Strategic Insights

— 2 min read

Pomerantz LLP has filed a class action lawsuit against Reckitt Benckiser Group Plc, a UK-based multinational consumer goods company, on behalf of investors who purchased or otherwise acquired the company's securities during a certain period. The lawsuit concerns allegations of securities fraud and other unlawful business practices by Reckitt and certain of its officers and/or directors. The lead plaintiff is appointed by the Court on August 4, 2025. A $60 million verdict was previously awarded against Reckitt's Mead Johnson subsidiary in an Illinois jury trial, and a $495 million verdict was awarded against Abbott Laboratories in a Missouri jury trial, both regarding the risk of necrotizing enterocolitis (NEC) in preterm infants. Reckitt's American Depositary Share price fell significantly after these verdicts.

Key Takeaways:

  • A class action lawsuit has been filed against Reckitt Benckiser Group Plc regarding allegations of securities fraud and other unlawful business practices.
  • The lawsuit is on behalf of investors who purchased or otherwise acquired Reckitt securities during the Class Period, and the lead plaintiff is appointed by the Court on August 4, 2025.
  • Reckitt's Mead Johnson subsidiary was previously found negligent in failing to warn about the increased risk of NEC in preterm infants, resulting in a $60 million verdict in an Illinois jury trial.
  • A Missouri jury awarded a $495 million verdict against Abbott Laboratories, making similar findings regarding Abbott's specialized baby formula and the risk of NEC.
  • Reckitt's American Depositary Share price fell significantly after these verdicts, with a $1.87 per share decrease on March 15, 2024, and a $1.02 per share decrease on July 29, 2024.
  • Pomerantz LLP notes that the verdicts demonstrate the risk of NEC associated with cow's milk-based formula in preterm infants.
  • Pomerantz LLP is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation.

Statistics:

  • A $60 million verdict was awarded against Reckitt's Mead Johnson subsidiary in an Illinois jury trial.
  • A $495 million verdict was awarded against Abbott Laboratories in a Missouri jury trial.
  • Reckitt's American Depositary Share price fell by $1.87 per share to $11.44 per share on March 15, 2024.
  • Reckitt's American Depositary Share price fell by $1.02 per share to $10.64 per share on July 29, 2024.
  • 85 years have passed since Pomerantz LLP was founded by the late Abraham L. Pomerantz.

Sources:

  • Pomerantz LLP
  • Pomerantz LLP's website
  • PRNewswire
  • OTCMKTS: RBGLY
  • Reckitt Benckiser Group Plc
  • Mead Johnson
  • Abbott Laboratories, Inc.

Read more